Press Release

Biochip Market to Grow with a CAGR of 14.46% through 2030

Increase in number of biochip applications and high adoption of personalized medication is expected to drive the Global Biochip Market growth in the forecast period, 2026-2030.

 

According to TechSci Research report, “Biochip Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the Global Biochip Market stood at USD 14.96 billion in 2022 and is anticipated to grow with a CAGR of 14.09% in the forecast period, 2026-2030. The increasing utilization of biochips in proteomics, genomics, and drug discovery, along with the growth in personalized medicine, is expected to drive market expansion.

Moreover, technological advancements and component miniaturization are anticipated to create favorable prospects for market players in the foreseeable future. Other factors contributing to market growth include the rise in the geriatric population, the increasing number of biochip applications, and the high adoption of personalized medications.

The biochip segment is witnessing significant growth as emerging players mature in the field. This can be attributed to the increasing adoption of personalized medicines, rising drug development, and the advent of next-generation sequencing (NGS). The global market growth is expected to be driven by innovation in Lab-on-a-chip offerings and advancements in microfluidic-based devices for biomedical applications. Lab-on-a-chip devices are anticipated to provide rapid results during the initial diagnosis of infectious diseases, making them widely utilized in epidemiological studies.

Researchers have found that biochips offer rapidity comparable to antigen tests and accuracy similar to PCR testing. The combination of biochip technology with various applications is projected to propel the growth of the biochip market. For example, in March 2022, Nutcracker, a U.S.-based startup, secured USD 167 million in series C funding to enhance their biochip-based RNA manufacturing platform. This platform is expected to support the advancement of RNA-based therapeutics. The biochip and nanoparticle delivery technologies aid in establishing comprehensive isolated and automated manufacturing processes. Furthermore, the growing use of biochip applications, including drug development, has compelled several R&D institutions and teams to design cost-effective and efficient processes. In 2021, there were over 700 drugs in progress targeting approximately 8,000 rare diseases.


The advancement of nanotechnology has increased the capability and reduced the size of biochips, making them valuable for diagnostics, research, drug development, and toxicology studies. This has led to growing adoption of biochips in various applications such as genomics, proteomics, and personalized medicine. Existing manufacturers and new startups are prompted to develop and invest in new technologies for the market. For instance, Dutch startup Qurin Diagnostics offers novel biomedical diagnostics using biochips. Their nanotechnology-based platform is used for monitoring, diagnosing, and treating cancer and other medical conditions. Similarly, on March 14, 2022, U.S. startup Nutcracker Therapeutics raised USD 167 million for the advancement of its mRNA biochip-based manufacturing platform. In May 2021, TU Wien developed a biochip capable of producing tissue beads in desired sizes and supplying them with drugs or nutrients.

The comprehensive drug development pipeline is one of the major factors driving the growth of the biochip market. The need to reduce turnaround time and miniaturize biological and clinical tests for research and diagnosis has increased the demand for biochip and bio-array techniques. Rapid technical developments related to these techniques and a wide product portfolio further accelerate the growth of the biochips market. Biochips find applications in disease marker identification, accelerated drug development, genotyping, proteomics, and genomics research. The rise in spending on clinical research and resource allocation for genomic and proteomic research also influence the biochips market. Additionally, factors such as the growth in the aging population, improving healthcare infrastructure, and surge in healthcare expenditure contribute positively to the biochips market. 

The high cost of manufacturing biochips creates barriers for new players to enter the market and produce a wide range of alternatives for end-users. Limited awareness among developing and under-developed regions about the utility of biochips is also a concerning factor for the global biochip market. Over the years, the quantity of biochip-based research conducted by research and academic institutes in developing countries has decreased. Moreover, the limited knowledge among emerging companies in the drug development and personalized medicine sector is projected to hinder global market growth.The Global Biochip Market is segmented into technology, type, application, end user, regional distribution, and company.

                                                                                             

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Biochip Market.”

 

Based on application, Drug Discovery & Development is expected to grow at the fastest rate in the global biochip market due to the increasing need for rapid, high-throughput screening technologies that accelerate the identification of potential drug candidates. Biochips enable simultaneous analysis of thousands of biological interactions, significantly reducing time and cost in early-stage drug development. Their ability to detect genetic mutations, protein expressions, and cellular responses makes them essential for understanding disease mechanisms and evaluating compound efficacy. With the rise of targeted therapies and personalized medicine, pharmaceutical companies are leveraging biochip technologies to streamline clinical trials, improve accuracy, and enhance decision-making, driving strong growth in this application segment. 

Based on region, Asia Pacific is growing exponentially in the global biochip market due to rapid advancements in healthcare infrastructure, increasing government funding for biotechnology, and rising adoption of precision medicine. Countries like China, India, Japan, and South Korea are heavily investing in genomics, diagnostics, and life sciences research. Additionally, a growing patient population with chronic and genetic conditions is boosting the demand for early and accurate diagnostic tools. The presence of skilled researchers, expanding clinical trial activities, and the emergence of local biotech startups are also accelerating the integration of biochip technologies across both clinical and research settings in the region.

Major companies operating in Global Biochip Market are:

  • Abbott Laboratories Inc.
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Fluidigm Corporation
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • Illumina Inc.
  • Phalanx Biotech Group Inc.
  • BioMerieux SA
  • Qiagen NV

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The rising prevalence of chronic diseases like diabetes, blood pressure, and COPD supports the global market growth. The increased utilization of biochips in genomics, proteomics, and molecular diagnostics also has a positive impact. Benefits such as time and cost reduction, high throughput, and no heavy instrument requirement contribute to market growth. The demand for timesaving, high-quality devices in the healthcare industry, along with the preference for personalized medicines and NGS, drives market growth. Biochips are also used for early cancer detection and offer lucrative opportunities. The growing geriatric population, demand for biochips in drug development, and biomedical advancements in microfluidic-based devices and lab-on-a-chip technologies drive market growth.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

Biochip Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Microarray v/s Microfluidics), By Type (DNA Chips, Lab-On-a-Chips, Protein Chips, Others), By Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, In-vitro diagnostics, Others), By End User (Hospitals & Diagnostics Centers, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Others), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Biochip Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Biochip Market.


Contact

TechSci Research LLC                                                                                              

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602                                             

Email: sales@techsciresearch.com               

Website: https://www.techsciresearch.com               

Relevant News